Watch this on-demand webinar held on July 06, 2022, to learn more about the new emerging technologies to develop covalent therapeutics.
In this webinar, Simon Haydar, SVP & Head, Integrated Drug Discovery Solutions at Aragen Life Sciences will highlight on new emerging technologies to develop covalent therapeutics, which can potentially be a strategy to overcome drug-resistance mutations in the gene encoding the target protein like in case of the epidermal growth factor receptor (EGFR).
Simon Haydar
SVP & Head, Integrated Drug Discovery Solutions, Aragen Life Sciences
Simon Haydar
SVP & Head, Integrated Drug Discovery Solutions, Aragen Life Sciences
